PSORS1C1
Basic information
Region (hg38): 6:31114750-31140092
Previous symbols: [ "C6orf16" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Peeling skin syndrome 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSORS1C1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 47 | 22 | 47 | 120 | ||
Total | 1 | 3 | 51 | 23 | 55 |
Highest pathogenic variant AF is 0.0000394
Variants in PSORS1C1
This is a list of pathogenic ClinVar variants found in the PSORS1C1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-31115879-G-A | Benign (Nov 10, 2018) | |||
6-31115887-G-A | Benign (Nov 10, 2018) | |||
6-31115952-A-C | Benign (Nov 11, 2018) | |||
6-31116020-ACTT-A | Benign (Oct 27, 2021) | |||
6-31116034-GT-G | Uncertain significance (Nov 27, 2023) | |||
6-31116036-T-C | Peeling skin syndrome 1 | Benign (Jan 31, 2024) | ||
6-31116048-C-T | Uncertain significance (Apr 06, 2020) | |||
6-31116083-G-A | Uncertain significance (Jul 10, 2023) | |||
6-31116089-A-G | CDSN-related disorder | Likely benign (Dec 30, 2023) | ||
6-31116090-G-A | Peeling skin syndrome 1;Hypotrichosis 2 | Benign/Likely benign (Jul 01, 2024) | ||
6-31116093-G-T | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
6-31116099-C-T | Inborn genetic diseases | Uncertain significance (Dec 16, 2023) | ||
6-31116100-T-C | Likely benign (Mar 08, 2023) | |||
6-31116117-G-A | Uncertain significance (Oct 12, 2022) | |||
6-31116125-C-T | not specified | Uncertain significance (Jan 01, 2019) | ||
6-31116156-C-T | Peeling skin syndrome 1 | Likely pathogenic (May 28, 2019) | ||
6-31116168-C-T | not specified • CDSN-related disorder | Benign/Likely benign (Jan 22, 2024) | ||
6-31116171-C-T | Uncertain significance (Mar 31, 2023) | |||
6-31116174-C-A | Uncertain significance (Jul 13, 2023) | |||
6-31116174-C-T | Inborn genetic diseases • CDSN-related disorder | Uncertain significance (Oct 06, 2022) | ||
6-31116202-G-A | CDSN-related disorder | Benign (Oct 09, 2023) | ||
6-31116203-G-A | Inborn genetic diseases | Uncertain significance (Nov 17, 2023) | ||
6-31116250-AG-A | Uncertain significance (Nov 28, 2022) | |||
6-31116257-C-T | Peeling skin syndrome 1 • CDSN-related disorder | Benign (Jan 29, 2024) | ||
6-31116271-A-G | Benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSORS1C1 | protein_coding | protein_coding | ENST00000259881 | 4 | 25343 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000265 | 0.344 | 125318 | 0 | 46 | 125364 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.681 | 62 | 79.0 | 0.784 | 0.00000382 | 972 |
Missense in Polyphen | 5 | 3.7535 | 1.3321 | 49 | ||
Synonymous | 0.861 | 26 | 32.2 | 0.807 | 0.00000179 | 320 |
Loss of Function | -0.249 | 5 | 4.43 | 1.13 | 1.89e-7 | 47 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00162 | 0.00162 |
European (Non-Finnish) | 0.0000637 | 0.0000619 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.000327 | 0.000327 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.856
- rvis_EVS
- 1.88
- rvis_percentile_EVS
- 97.25
Haploinsufficiency Scores
- pHI
- 0.0987
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0213
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |